Ir.bauschhealth.com

News Releases – Bausch Health Companies Inc.

WebBausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain …

Actived: 1 days ago

URL: https://ir.bauschhealth.com/news-releases

Bausch Health Announces Fourth-Quarter and Full-Year …

WebLAVAL, QC, February 22, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" the "Company," "we" or "our") today announced its fourth-quarter and …

Category:  Health Go Health

Bausch Health Announces Second-Quarter 2023 Results, …

WebHome » Investor Relations » News Releases » 2023 » Bausch Health Announces Second-Quarter 2023 Results, other key updates from the Quarter, and …

Category:  Health Go Health

Bausch Health Announces Positive Topline Results From …

WebTrial Meets Both Primary and Key Secondary Endpoints. LAVAL, Quebec, December 21, 2023 – Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch …

Category:  Health Go Health

Bausch Health Provides Update on Solta Medical

WebLAVAL, QB, June 16, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced an update on its previously …

Category:  Health Go Health

Salix Pharmaceuticals Announces a Phase 2 Investigator …

WebLAVAL, Quebec, March 6, 2024 –– Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced that it is …

Category:  Health Go Health

Based on a New Survey, More Than Half of Surveyed …

WebSalix Pharmaceuticals Releases Fourth Annual Patient Perspectives IBS Impact Report. LAVAL, QC / ACCESSWIRE / April 2, 2024 / Bausch Health Companies …

Category:  Health Go Health

Bausch Health to Announce Fourth-Quarter and Full-Year …

Web.Feb {background-color: white} LAVAL, Quebec, Feb. 1, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) will release fourth- quarter and full-year 2023 …

Category:  Health Go Health

Bausch Health’s Bausch + Lomb Announces Completion …

WebLAVAL, Quebec, September 29, 2023 – Bausch + Lomb Corporation (“Bausch + Lomb”) (NYSE/TSX: BLCO), a subsidiary of Bausch Health Companies Inc. (the “Company” or …

Category:  Health Go Health

Bausch Health Announces Third-Quarter 2023 Results

WebThird Quarter 2023 Revenue Performance. Total reported revenues were $2.24 billion for the third quarter of 2023, compared with $2.05 billion in the third quarter of 2022, an …

Category:  Health Go Health

Solta Medical’s Thermage® FLX and TR-4 Return Pad Receive …

WebApproval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets. LAVAL, Quebec, January 18, 2024 -- Bausch Health …

Category:  Medical Go Health

FDA Approves CabtreoTM (clindamycin phosphate, adapalene and …

WebFirst and only FDA-approved fixed-dose, triple-combination topical treatment. LAVAL, Quebec, Oct. 20, 2023 – Bausch Health Companies Inc. (NYSE/TSX: BHC) …

Category:  Health Go Health

Salix Announces 2024 Gastrointestinal Health Scholars Program

WebLAVAL, Quebec, Feb. 12, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced the opening of the 2024 Salix Gastrointestinal Health Scholars Program …

Category:  Health Go Health

Ortho Dermatologics Announces 2021 Aspire Higher

WebScholarships Awarded to Nine Students Affected by Dermatologic Conditions. LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. …

Category:  Health Go Health

Court of Appeals for the Federal Circuit Hears Oral Arguments on …

WebLAVAL, Quebec, January 8, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, as …

Category:  Health Go Health

New Bausch Health treatment PrUCERIS® (budesonide) aerosol …

WebLAVAL, QE / ACCESSWIRE / September 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce that following its …

Category:  Health Go Health

Salix To Present Clinical Data At United European

WebScientific Posters Span Across Salix's Gastroenterology Portfolio BRIDGEWATER, N.J., Oct. 8, 2020 /PRNewswire/ -- Bausch Health Companies Inc. …

Category:  Health Go Health

3Q 21 Financial Results

Web1 This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, “forward-looking …

Category:  Health Go Health

Bausch Health Enters Into Arrangement Agreement with Bausch

WebLAVAL, QC and VAUGHAN, ON, April 28, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") …

Category:  Health Go Health

FDA APPROVES CABTREOTM (CLINDAMYCIN PHOSPHATE, …

Web4 | Page • Allergic reactions: Stop using CABTREO if you have hives, rash, severe itching, swelling of your face, eyes, lips, tongue or throat, trouble breathing, throat tightness, …

Category:  Health Go Health

Valeant Will Become Bausch Health Companies Inc.

WebLAVAL, Quebec, May 8, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company" or "we") today announced that the …

Category:  Health Go Health

Salix Expands Microbiome Research and Discovery Through …

Web2 | Page Salix has the option to acquire any therapeutic invention discovered through the research. “My philosophy is to treat these microorganisms – in other words – …

Category:  Health Go Health